Opus Genetics, Inc.
IRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001228627
In the last 90 days, Opus Genetics, Inc. insiders filed 0 open-market purchases and 5 sales; 103 institutions reported holding it in 13F filings for Q2 2026, worth $236.4M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Opus Genetics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 30 | 40 | +10 |
| Shares | 1.68M | 2.17M | +490.5K (+29.2%) |
| Value | $8.62M | $8.07M | −$547.0K (−6.3%) |
New holders (13)
Institutions that held Opus Genetics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rice Hall James & Associates, LLC | 132,433 | $494.0K | 0.02% |
| Diametric Capital, LP | 89,442 | $334.0K | 0.26% |
| Richmond Brothers, Inc. | 74,420 | $277.0K | 0.20% |
| Prelude Capital Management, LLC | 52,463 | $196.0K | 0.01% |
| Renaissance Technologies LLC | 19,361 | $72.0K | 0.00% |
| Dimensional Fund Advisors LP | 16,575 | $62.0K | 0.00% |
| Squarepoint Ops LLC | 10,655 | $40.0K | 0.00% |
| Byrne Asset Management LLC | 2,176 | $8.00K | 0.01% |
| CarsonAllaria Wealth Management, Ltd. | 1,000 | $4.00K | 0.00% |
| Aspire Private Capital, LLC | 400 | $1.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 1 | $0 | 0.00% |
| Cutler Group LP | 100 | $0 | 0.00% |
| Cornerstone Advisory, LLC | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Opus Genetics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 57,502 | $296.0K |
| Regency Capital Management Inc. | 15,000 | $77.0K |
| MCF Advisors LLC | 9,499 | $49.0K |